You are here

Escape Smoke Project: Non-Intervention Non-Drug Multicenter Study on the Real-life Effectiveness of Smoking Cessation in General Practice in Denmark

Last updated on May 9, 2018

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Smoking Cessation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18+ years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Smoking males or females aged 18 years or older.

- Subjects being motivated for and willing to quit smoking.

- Ability to read and understand Danish.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Not smoking.

- Aged below 18 years.

- Lack of motivation and willingness to quit smoking.

- Do not read and understand Danish.

- Is not willing to cooperate with the clinic staff.

NCT01544621
Pfizer
Completed
Escape Smoke Project: Non-Intervention Non-Drug Multicenter Study on the Real-life Effectiveness of Smoking Cessation in General Practice in Denmark

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Smoking Cessation
NCT01312909
All Genders
12+
Years
Multiple Sites
Smoking Cessation
NCT00143299
All Genders
18+
Years
Multiple Sites
Smoking Cessation
NCT00150241
All Genders
18+
Years
Multiple Sites
Escape Smoke Project: Non-Intervention Non-Drug Multicenter Study on the Real-life Effectiveness of Smoking Cessation in General Practice in Denmark
Escape Smoke Project: Non-Intervention Multicenter Study On the Real-Life Effectiveness of Smoking Cessation in General Practice in Denmark
Real life smoking cessation rates after 24 weeks non-intervention design. Approximately 40 General Practice (GP) centers with 800 smokers will participate.
Active smokers who wish to quit seen at in primary care practices
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Active smokers who wish to quit
Smoking Cessation
Other: Smoking cessation
Smoking cessation
Successful quitters Sustained smokers
Successful quitters
Intervention: Other: Smoking cessation
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
544
May 2013
May 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Smoking males or females aged 18 years or older.
  • Subjects being motivated for and willing to quit smoking.
  • Ability to read and understand Danish.

Exclusion Criteria:

  • Not smoking.
  • Aged below 18 years.
  • Lack of motivation and willingness to quit smoking.
  • Do not read and understand Danish.
  • Is not willing to cooperate with the clinic staff.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01544621
A3051150
No
Not Provided
Not Provided
Pfizer
Pfizer
Technical University of Denmark (DTU)
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
May 2013

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now